@prefix biolink: .
@prefix ns1: .
@prefix this: .
@prefix sub: .
@prefix schema: .
@prefix np: .
@prefix dct: .
@prefix rdf: .
@prefix xsd: .
@prefix rdfs: .
@prefix orcid: .
@prefix prov: .
@prefix npx: .
sub:Head {
this: np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo;
a np:Nanopublication .
}
sub:assertion {
biolink:category biolink:Disease .
sub:association rdf:object ;
rdf:predicate biolink:treats;
rdf:subject ;
a rdf:Statement;
rdfs:label "\"Doxercalciferol is contraindicated in patients with: Hypercalcemia [see Warnings and Precautions (5.1) Vitamin D toxicity [see Warnings and Precautions (5.1) Known hypersensitivity to doxercalciferol or any of the inactive ingredients of Doxercalciferol capsules or HECTOROL injection; serious hypersensitivity reactions including anaphylaxis and angioedema have been reported [see Warnings and Precautions (5.3) Adverse Reactions (6.2) Hypercalcemia ( 4 Vitamin D toxicity ( 4 Know hypersensitivity to doxercalciferol or any of the inactive ingredients of Doxercalciferol capsules or HECTOROL injection ( 4\"";
biolink:provided_by ;
biolink:relation schema:MedicalContraindication .
biolink:category biolink:Drug .
}
sub:provenance {
sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}
sub:pubinfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
npx:hasSignature "ZzrzNhXi04iIg0IB1vIMUL0q1AhPueZQZ3MQwbLwYRq8Pp9ekqSC8YtFWCHQjo+mlWQ4PRlI6Qp8tMBfY2QvTaywSutEZW+ndvBRbBew4ojfn2y7NUQbAsOQ+q6aJa2toAnvwtpxBki26iKE98IEq+KR5cheQ6zhJEnGd9XPFlQ=";
npx:hasSignatureTarget this: .
this: dct:created "2021-08-25T13:55:35.064+02:00"^^xsd:dateTime;
dct:creator orcid:0000-0002-1468-3557;
ns1:wasCreatedFromProvenanceTemplate ;
ns1:wasCreatedFromPubinfoTemplate ;
ns1:wasCreatedFromTemplate .
}